Anika Therapeutics, Inc. Sample Contracts

EXHIBIT 10.2
Employment Agreement • September 14th, 2009 • Anika Therapeutics Inc • Surgical & medical instruments & apparatus • Massachusetts
AutoNDA by SimpleDocs
CREDIT AGREEMENT
Credit Agreement • October 27th, 2017 • Anika Therapeutics, Inc. • Surgical & medical instruments & apparatus • New York

This CREDIT AGREEMENT is entered into as of October 24, 2017, among ANIKA THERAPEUTICS, INC., a Massachusetts corporation (the “Borrower”), the Subsidiaries of the Borrower as are or may from time to time become parties to this Agreement as Subsidiary Guarantors (defined herein), the Lenders (defined herein), and BANK OF AMERICA, N.A., as Administrative Agent, Swingline Lender and L/C Issuer.

SECOND AMENDMENT TO EXCLUSIVE DISTRIBUTION AGREEMENT
Exclusive Distribution Agreement • May 15th, 2000 • Anika Therapeutics Inc • Biological products, (no disgnostic substances) • New York
Anika Therapeutics, Inc. and American Stock Transfer & Trust Company as Rights Agent Shareholder Rights Agreement
Shareholder Rights Agreement • April 7th, 2008 • Anika Therapeutics Inc • Surgical & medical instruments & apparatus • Massachusetts

Agreement, dated as of April 7, 2008, between Anika Therapeutics, Inc., a Massachusetts corporation (the “Company”), and American Stock Transfer & Trust Company, a New York corporation (the “Rights Agent”).

ANIKA THERAPEUTICS, INC. NON-DISCLOSURE AND NON-COMPETITION AGREEMENT EMPLOYEE
Anika Therapeutics Inc • August 14th, 2000 • Biological products, (no disgnostic substances) • Massachusetts
SECURITY AND PLEDGE AGREEMENT
Security and Pledge Agreement • October 27th, 2017 • Anika Therapeutics, Inc. • Surgical & medical instruments & apparatus

This SECURITY AND PLEDGE AGREEMENT (as amended, modified, extended, restated, renewed, replaced, or supplemented from time to time, this “Agreement”) is entered into as of October 24, 2017 among ANIKA THERAPEUTICS, INC., a Massachusetts corporation (the “Borrower”), the Subsidiaries of the Borrower identified as “Grantors” on the signature pages hereto and such other parties that may become Grantors hereunder after the date hereof (together with the Borrower, each individually a “Grantor”, and collectively, the “Grantors”) and BANK OF AMERICA, N.A., in its capacity as administrative agent (in such capacity, the “Administrative Agent”) for the Secured Parties.

June 15, 2001
Letter Agreement • August 14th, 2001 • Anika Therapeutics Inc • Biological products, (no disgnostic substances) • Massachusetts
and
Shareholder Rights Agreement • April 7th, 1998 • Anika Therapeutics Inc • Biological products, (no disgnostic substances) • Massachusetts
ANIKA THERAPEUTICS, INC. Form of Change in Control, Bonus and Severance Agreement
Agreement • November 19th, 2004 • Anika Therapeutics Inc • Biological products, (no disgnostic substances) • Massachusetts

AGREEMENT made as of October 6, 2004 by and among Anika Therapeutics, Inc., a Massachusetts corporation with its principal place of business in Woburn, Massachusetts (the “Company”), and Carol A. Toth, of East Walpole, Massachusetts (the “Executive”), an individual presently employed as the Senior Vice President Marketing and Business Development of the Company.

DIRECTOR INDEMNIFICATION AGREEMENT
Indemnification Agreement • November 6th, 2014 • Anika Therapeutics, Inc. • Surgical & medical instruments & apparatus • Massachusetts

This Indemnification Agreement (“Agreement”) is made as of November 5, 2014 by and between Anika Therapeutics, Inc., a Massachusetts corporation (the “Company”), and ____________ (“Indemnitee”).

INCENTIVE STOCK OPTION AGREEMENT UNDER THE ANIKA THERAPEUTICS, INC. 2003 STOCK OPTION AND INCENTIVE PLAN
Incentive Stock Option Agreement • October 5th, 2004 • Anika Therapeutics Inc • Biological products, (no disgnostic substances)

Pursuant to the Anika Therapeutics, Inc. 2003 Stock Option Incentive Plan (the “Plan”) as amended through the date hereof, Anika Therapeutics, Inc. (the “Company”) hereby grants to the Optionee named above an option (the “Stock Option”) to purchase on or prior to the Expiration Date specified above all or part of the number of shares of Common Stock, par value $.01 per share (the “Stock”) of the Company specified above at the Option Exercise Price per Share specified above subject to the terms and conditions set forth herein and in the Plan.

ANIKA THERAPEUTICS, INC. EXECUTIVE RETENTION AGREEMENT
Executive Retention Agreement • March 16th, 2023 • Anika Therapeutics, Inc. • Surgical & medical instruments & apparatus • Massachusetts

Anika Therapeutics, Inc., a Massachusetts corporation (the “Company”), and [David Colleran] (the “Executive”) enter into this Executive Retention Agreement (the “Agreement”) dated as of March 9th, 2020 (the “Effective Date”).

Fixed Dollar Accelerated Share Repurchase Transaction
Letter Agreement • July 26th, 2019 • Anika Therapeutics, Inc. • Surgical & medical instruments & apparatus • New York

The purpose of this letter agreement (this “Confirmation”) is to confirm the terms and conditions of the Transaction entered into between Morgan Stanley & Co. LLC (“MSCO”) and Anika Therapeutics, Inc. (“Issuer”) on the Trade Date specified below (the “Transaction”). This confirmation constitutes a “Confirmation” as referred to in the Agreement specified below.

AutoNDA by SimpleDocs
CREDIT AGREEMENT Dated as of January 31, 2008 among ANIKA THERAPEUTICS, INC. as Borrower, ANIKA SECURITIES, INC. as a Guarantor,
Credit Agreement • February 6th, 2008 • Anika Therapeutics Inc • Surgical & medical instruments & apparatus • Massachusetts

CREDIT AGREEMENT (this “Agreement”) is entered into as of January 31, 2008 among ANIKA THERAPEUTICS, INC., a Massachusetts corporation (“Borrower”), ANIKA SECURITIES, INC., a Massachusetts securities corporation (“Anika Securities”), each lender from time to time party hereto (collectively, “Lenders” and individually, a “Lender”), and BANK OF AMERICA, N.A., as Administrative Agent.

and
Shareholder Rights Agreement • April 7th, 1998 • Anika Therapeutics Inc • Biological products, (no disgnostic substances) • Massachusetts
CUMMINGS PROPERTIES STANDARD FORM COMMERCIAL LEASE
Anika Therapeutics Inc • April 2nd, 2001 • Biological products, (no disgnostic substances) • Massachusetts
PLEDGE AGREEMENT ON A QUOTA OF FIDIA ADVANCED BIOPOLYMERS S.r.l.
Pledge Agreement • May 10th, 2010 • Anika Therapeutics Inc • Surgical & medical instruments & apparatus

THIS PLEDGE AGREEMENT is entered in Boston, Massachusetts (U.S.A.), on March 12, 2010, by ANIKA THERAPEUTICS, INC., a company duly incorporated under the laws of Massachusetts, whose registered office is at 32 Wiggins Avenue, Bedford, Massachusetts 01730 Italian tax code number 97542640152, acting by its legal representative Dr. Charles Sherwood (the “Pledgor”), in favor of BANK OF AMERICA, N.A., bank association, incorporated under the laws of United States of America, with legal office in North Tryon Street 100, Charlotte, North Carolina (U.S.A.) (“Bank of America”);

Exhibit 10.8 Cummings Properties Management, Inc. Standard Form
Anika Therapeutics Inc • April 2nd, 2001 • Biological products, (no disgnostic substances) • Massachusetts
AMENDMENT NO. 1 TO EMPLOYMENT AGREEMENT
Employment Agreement • March 16th, 2011 • Anika Therapeutics Inc • Surgical & medical instruments & apparatus

THIS AMENDMENT NO. 1 (“Amendment No. 1”) to the EMPLOYMENT AGREEMENT (the “Agreement”) by and between Kevin Quinlan (the “Executive”) and Anika Therapeutics, Inc., a Massachusetts corporation (the “Corporation”), dated as of October 17, 2008, is made this 8th day of December, 2010.

EMPLOYMENT AGREEMENT
Employment Agreement • May 5th, 2014 • Anika Therapeutics, Inc. • Surgical & medical instruments & apparatus • Massachusetts

This Employment Agreement (“Agreement”) is made as of the 22nd day of March, 2010 between Anika Therapeutics, Inc., a Massachusetts corporation (the “Company”), and Sylvia Cheung (the “Executive”).

RESTRICTED STOCK AWARD AGREEMENT UNDER THE ANIKA THERAPEUTICS, INC. 2003 STOCK OPTION AND INCENTIVE PLAN
Restricted Stock Award Agreement • March 12th, 2008 • Anika Therapeutics Inc • Surgical & medical instruments & apparatus

Pursuant to the Anika Therapeutics, Inc. 2003 Stock Option and Incentive Plan (the "Plan") as amended through the date hereof, Anika Therapeutics, Inc. (the "Company") hereby grants a Restricted Stock Award (an "Award") to the Grantee named above. Upon acceptance of this Award, the Grantee shall receive the number of shares of Common Stock, par value $0.01 per share (the "Stock") of the Company specified above, subject to the restrictions and conditions set forth herein and in the Plan.

Form of Change in Control, Bonus and Severance Agreement
Severance Agreement • July 12th, 2005 • Anika Therapeutics Inc • Surgical & medical instruments & apparatus • Massachusetts

AGREEMENT made as of July 11, 2005 by and among Anika Therapeutics, Inc., a Massachusetts corporation with its principal place of business in Woburn, Massachusetts (the “Company”), and Kevin W. Quinlan, with his principal residence in Marblehead, MA, (the “Executive”), an individual presently employed as the Chief Financial Officer of the Company.

Sale and Purchase Agreement by and between Fidia Farmaceutici S.p.A. as seller and Anika Therapeutics Inc. as buyer
Sale and Purchase Agreement • January 6th, 2010 • Anika Therapeutics Inc • Surgical & medical instruments & apparatus

Exhibit A Powers of the Seller. Exhibit B Powers of the Buyer. Exhibit 1.03(I) Amendments to Existing Product Agreements. Exhibit 1.03(II) Final drafts of the Commercial Agreements. Exhibit 1.03(III) Company’s Receivables. Exhibit 1.03(IV) Executed copy of the Escrow Agreement. Exhibit 1.03(V) Financial statements for the years ended on December 31, 2007 and December 31, 2008. Exhibit 1.03(VI) Interim Financial Statements. Exhibit 1.03(VII) Registration Rights Agreement. Exhibit 1.03(VIII) Seller’s Receivables. Exhibit 2.03(a)(ii) Executed copies of (i) product registration transfer agreement and (ii) trademark transfer agreements. Exhibit 2.03(a)(v) Deed of Transfer. Exhibit 2.04(b) New Board of Directors. Exhibit 3.02 Bank account details. Exhibit 4.01 Estimated Closing Balance Sheet and Estimated Net Working Capital. Exhibit 4.02 Table related to (i) the Closing Balance Sheet and (ii) the Closing Net Working Capital. Exhibit 9.05 Assumed Obligations. Exhibit 9.15 Insurances.

AMENDMENT NO. 1 TO EMPLOYMENT AGREEMENT
Employment Agreement • May 5th, 2014 • Anika Therapeutics, Inc. • Surgical & medical instruments & apparatus

THIS AMENDMENT NO. 1 (“Amendment No. 1”) to the EMPLOYMENT AGREEMENT (the “Agreement”) by and between Sylvia Cheung (the “Executive”) and Anika Therapeutics, Inc., a Massachusetts corporation (the “Corporation”), dated as of March 22, 2010, is made this 8th day of December, 2010.

Re: Transitional Services and Separation Agreement
Anika Therapeutics, Inc. • May 8th, 2024 • Surgical & medical instruments & apparatus • Massachusetts

This letter agreement follows our conversations regarding your employment with Anika Therapeutics, Inc. (the “Company”). This confirms that you will be transitioning and resigning from your employment. We appreciate your contributions and would like to work with you to make this transition as smooth as possible. Consistent with that, this letter is to express the parties’ mutual understanding and promises concerning the orderly transition of your responsibilities and the ultimate termination of your employment at the Company.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!